SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-22-000026
Filing Date
2022-05-03
Accepted
2022-05-03 16:08:45
Documents
18
Period of Report
2022-05-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bbi-20220503.htm   iXBRL 8-K 48984
2 EX-10.1 a202205038kex101.htm EX-10.1 565065
3 EX-10.2 a202205038kex102.htm EX-10.2 74810
4 EX-10.3 a202205038kex103.htm EX-10.3 57376
5 EX-99.1 a202205038kex991.htm EX-99.1 20118
9 bbi-20220503_g1.jpg GRAPHIC 6568
10 bbilogohr.jpg GRAPHIC 71984
  Complete submission text file 0000819050-22-000026.txt   1136303

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20220503.xsd EX-101.SCH 1909
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20220503_lab.xml EX-101.LAB 25154
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20220503_pre.xml EX-101.PRE 13055
12 EXTRACTED XBRL INSTANCE DOCUMENT bbi-20220503_htm.xml XML 11253
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 22886894
SIC: 2836 Biological Products, (No Diagnostic Substances)